April 05, 2021
Article
After reviewing the mechanisms of the first three COVID-19 vaccines granted emergency use authorization, we can now address some of the most common concerns that have been expressed regarding vaccine hesitancy.
This week on Pharmacy Times, there are a number of important topics that will be covered and posted throughout the week
April 02, 2021
The Pfizer and BioNTech vaccine was 100% effective in preventing COVID-19 cases in South Africa, where the B.1.351 variant is prevalent.
Patients who received a flu shot during the last flu season were significantly less likely to test positive for a COVID-19 infection at the start of the pandemic, according to a study published in the American Journal of Infection Control.
Pharmacist-led services are not only important during COVID-19 immunization efforts in the United States, but are additionally critical in vaccination endeavors globally.
March 31, 2021
The results from a phase 3 trial in a population of American adolescents aged 12 to 15 years found that the Pfizer-BioNTech COVID-19 vaccine BNT162b2 showed 100% efficacy and robust antibody responses.
March 30, 2021
The Biden administration has moved to activate 40,000 local pharmacies within the Federal Retail Pharmacy Program, which is a part of the administration’s national COVID-19 vaccination strategy.
March 29, 2021
The APhA and the CDC announced that they have entered into a collaborative agreement focused on supporting the role of pharmacists in building the public’s confidence in COVID-19 vaccines.
This week on Pharmacy Times, there are a number of important topics that will be covered and posted throughout the week.
Daily national surveys by Carnegie Mellon University (CMU) show that although COVID-19 vaccine uptake has increased, the proportion of vaccine-hesitant adults has remained unchanged.
